Latest Forum Topics /
Clearbridge
Last:0.001
-0.001
|
 Post Reply
|
|
Medical Stock - Strong Shareholders
|
|||||
|
MarcLim
Veteran |
16-Feb-2021 20:09
|
||||
|
x 0
x 0 Alert Admin |
Thanks Hope market realized it potential soon. Good revenue and profits report! See 17-18-19-20 if gap up Huat all
|
||||
| Useful To Me Not Useful To Me | |||||
|
Charanko
Senior |
16-Feb-2021 20:01
|
||||
|
x 0
x 0 Alert Admin |
Should be 2 weeks time..... This should worth at least $0.2
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
MarcLim
Veteran |
16-Feb-2021 19:48
|
||||
|
x 0
x 0 Alert Admin |
when result out?
|
||||
| Useful To Me Not Useful To Me | |||||
|
FlyingCat
Master |
16-Feb-2021 13:09
|
||||
|
x 0
x 0 Alert Admin |
think this one is coming | ||||
| Useful To Me Not Useful To Me | |||||
|
MarcLim
Veteran |
13-Feb-2021 16:14
|
||||
|
x 0
x 0 Alert Admin |
bought small 0.15 low for result play. Hope awaken soon and become ninja turtle again. Huat.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
sgreat
Member |
05-Feb-2021 11:12
|
||||
|
x 0
x 0 Alert Admin |
Q& M is bounce up http://www.sharejunction.com/sharejunction/listMessage.htm?topicId=15743& msgbdName=Q& M%20Dental& topicTitle=Q& M%20dental
|
||||
| Useful To Me Not Useful To Me | |||||
|
MarcLim
Veteran |
01-Feb-2021 10:43
|
||||
|
x 0
x 0 Alert Admin |
Joker. 100lot drop from 157 to 151. Good price at 151 DYDD
|
||||
| Useful To Me Not Useful To Me | |||||
|
MarcLim
Veteran |
27-Jan-2021 21:38
|
||||
|
x 0
x 0 Alert Admin |
Huge improvement. But Market not liking it. 168/169 got shot down. see when break above 170. leave it until report out. Or buy more at 160
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
WBdisciple
Elite |
27-Jan-2021 14:27
|
||||
|
x 0
x 0 Alert Admin |
The stock market is a beauty contest (market sentiment) in the short term BUT in the long run, it is a weighing machine (on Fundamentals). Jeremy Yee and team has proven that in 3 short years, they have built a pan-Asian healthcare network...with S$21million revenue and profits churning in (as compared to when they just listed at S$200k revenue and losses). |
||||
| Useful To Me Not Useful To Me | |||||
|
FlyingCat
Master |
27-Jan-2021 14:06
|
||||
|
x 1
x 0 Alert Admin |
Flying cat drill the ground more likely 飞 猫 遁 地
|
||||
| Useful To Me Not Useful To Me | |||||
|
sgreat
Member |
27-Jan-2021 09:39
|
||||
|
x 0
x 0 Alert Admin |
JOYSBIO' s COVID-19 antigen test kit is capable of detecting the new SARS-COV-2 strain found in the United Kingdom and the United Stateshttps://www.prnewswire.co.uk/news-releases/joysbio-s-covid-19-antigen-test-kit-is-capable-of-detecting-the-new-sars-cov-2-strain-found-in-the-united-kingdom-and-the-united-states-815161136.html
|
||||
| Useful To Me Not Useful To Me | |||||
|
WBdisciple
Elite |
27-Jan-2021 07:18
|
||||
|
x 0
x 0 Alert Admin |
Philippines confirms local transmission of more contagious UK variant
MANILA &bull The Philippines has confirmed domestic transmission of the new, highly contagious British variant of the coronavirus, prompting President Rodrigo Duterte to abandon a plan to allow some minors to go outside their homes.
Health Undersecretary Maria Rosario Vergeire told news channel ANC yesterday: " Right now, we have local transmission where this individual or these cases with the variant have already infected their community, their family."
Citing the British variant, Mr Duterte said he had scrapped a plan to allow children aged 10 to 14 in low-risk areas to go outside their home starting Feb 1.
The Philippines has imposed some of the world' s toughest restrictions to curb the spread of coronavirus infections, including internal travel bans. Since March last year, minors have been officially prohibited from leaving their home.
" I am afraid because this new strain strikes the young children," Mr Duterte said late on Monday.
" Go back to your homes... and besides, they' re good just with the TV. They can glue their attention to the TV the whole day."
The Philippine government had hoped that easing restrictions on children might boost economic activity, after a year when growth is expected to have contracted 8.5 per cent to 9.5 per cent.
Acting Socioeconomic Planning Secretary Karl Kendrick Chua said this month that 50 per cent of the economy was driven by " family activities" , and without them, the economy could not recover.
The Philippines' caseload of more than half a million infections is one of the highest in South-east Asia.
Mr Duterte' s administration also has been criticised for its slowness in procuring Covid-19 vaccines, with the bulk of them not expected to start arriving until the second half of the year.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Charanko
Senior |
26-Jan-2021 21:31
|
||||
|
x 0
x 0 Alert Admin |
Been holding this for months, hopefully tomorrow 飞 龙 在 天 。 。 。 。 |
||||
| Useful To Me Not Useful To Me | |||||
|
gregtan123
Supreme |
26-Jan-2021 21:24
|
||||
|
x 0
x 0 Alert Admin |
Yes, BEAR case TP min 0.197, that' s 3.2 cents from today' s close.
|
||||
| Useful To Me Not Useful To Me | |||||
|
WBdisciple
Elite |
26-Jan-2021 21:20
|
||||
|
x 0
x 0 Alert Admin |
Biolidics has Antibody test kit approved in Indonesia...and Clearbridge has distributionship rights for it in Indonesia... Indonesia set to pass 1 million coronavirus cases as vaccinations roll out TUE, JAN 26, 2021 - 12:41 PM [JAKARTA] Indonesia is set to officially surpass one million coronavirus cases on Tuesday, a grim milestone for the Southeast Asian nation that has struggled since last March to get the Covid-19 pandemic under control. The world' s fourth-most-populous country had recorded 999,256 coronavirus infections as of Monday, with the average daily increase running above 11,000 for more than a week, according to official data. Deaths from the respiratory disease have totalled 28,132. Those numbers are some of the highest in Asia but health experts believe the true spread is likely to be far worse. The government started its vaccination programme and tightened movement restrictions earlier this month as hospitals came under mounting strain. Indonesia has been criticised for having among the lowest testing and contact-tracing rates globally, and for focusing on securing vaccines at the expense of trying to enforce health protocols. Sabriyanti, a 42-year-old Jakarta resident, called for the government to impose tighter social distancing rules. " The government should be stricter, because we still can see crowds and those who don' t wear masks," she said. Muhaimin Zega, a 20-year-old college student, said the government should give " clear rules that people can understand" . " We can' t put all blame on the people, it' s the government' s responsibility to control its people," he said. Reisa Broto Asmoro, the spokeswoman for the government' s Covid-19 task force, said 80 per cent of people who had caught the virus had fully recovered. |
||||
| Useful To Me Not Useful To Me | |||||
|
MarcLim
Veteran |
26-Jan-2021 08:51
|
||||
|
x 0
x 0 Alert Admin |
Today turtle power? Good time for BB to fry clear 169/170 then toward 180.
|
||||
| Useful To Me Not Useful To Me | |||||
|
gregtan123
Supreme |
26-Jan-2021 00:38
|
||||
|
x 0
x 0 Alert Admin |
it' s 2021: ANYTHING CAN HAPPEN. $Clearbridge(1H3.SI) and $Biolidics(8YY.SI) BREAKING NEWS
Launch of the ClearEpi SARS-CoV-2 Antigen Rapid Test Kit The board of directors (the " Board" , and each a " Director" ) of Biolidics Limited (the " Company" , and together with its subsidiaries, the " Group" ) is pleased to announce that, on 25 January 2021, the Company has launched a SARS-CoV-2 antigen test kit, the " ClearEpi SARS-CoV-2 Antigen Rapid Test Kit" (the " ClearEpi ART" ).
The raw materials of the ClearEpi ART are sourced from JOYSBIO (Tianjin) Biotechnology Co, Ltd, with whom the Company has a distribution agreement with, and the ClearEpi ART are packaged and labelled by third party manufacturers.
Launch of the ClearEpi SARS-CoV-2 Antigen Rapid Test Kit The board of directors (the " Board" , and each a " Director" ) of Biolidics Limited (the " Company" , and together with its subsidiaries, the " Group" ) is pleased to announce that, on 25 January 2021, the Company has launched a SARS-CoV-2 antigen test kit, the " ClearEpi SARS-CoV-2 Antigen Rapid Test Kit" (the " ClearEpi ART" ).
The raw materials of the ClearEpi ART are sourced from JOYSBIO (Tianjin) Biotechnology Co, Ltd, with whom the Company has a distribution agreement with, and the ClearEpi ART are packaged and labelled by third party manufacturers. 2. Receipt of Confirmation for CE Marking for the ClearEpi SARS-CoV-2 Antigen Rapid Test Kit The Board is also pleased to announce that it had, on 25 January 2021, received confirmation for the CE marking (registration number: DE/CA70/40838-160662 for the ClearEpi ART (the " CE Marking" ). The CE Marking is a notification process which enables the Company to market and sell the ClearEpi ART in the European Union (" EU" ).
The CE Marking indicates that the ClearEpi ART complies with the relevant EU safety, health and environmental protection requirements which enables the ClearEpi ART to be marketed in the EU. It should be noted that antigen rapid test kits, such as the ClearEpi ART, are different from the serology rapid test kits for the detection of COVID-19 antibodies that are currently being sold by the Company (please refer to the Company' s announcement, among others, dated 30 March 2020). Specifically, serology tests (administered via blood draw) seek to detect antibodies that usually appear in patients during the recovery phase of COVID-19, whereas antigen tests (administered via nasal swab from the lower part of the nose) seek to detect viral proteins (i.e. antigens) in patients during the acute phase of COVID-19.
Serology tests and antigen tests are beneficial for their ability to produce test results quickly and at lower costs as compared to the more expensive polymerase chain reaction (" PCR" ) tests which typically take between one to two days to produce test results. In this regard, given the growing demand for antigen rapid test kits, the Company has decided to further expand its COVID-19 test kit offerings to customise and manufacture its own range of antigen test kits. However, serology tests and antigen tests have lower sensitivity and specificity than PCR tests which are administered via nasopharyngeal or oropharyngeal swabs to obtain respiratory samples.
For this reason, the results from the ClearEpi ART are only for clinical reference and should not be the only basis for clinical diagnosis and treatment. The clinical management of patients should be considered in combination with their symptoms, physical signs, medical history, other laboratory tests, therapeutic reaction, and epidemiological information. Barring unforeseen circumstances, and given the ongoing COVID-19 pandemic, the launch of the ClearEpi ART and/or the CE Marking are expected to contribute positively to the revenue of the Group for the current financial year ending 31 December 2021. However, the Company is unable to quantify such financial impact as the sales uptake of the ClearEpi ART cannot be determined as at the date of this announcement.
|
||||
| Useful To Me Not Useful To Me | |||||
|
wehuattogether88
Supreme |
20-Jan-2021 18:47
|
||||
|
x 0
x 0 Alert Admin |
This stock moving up slowly and quietly. | ||||
| Useful To Me Not Useful To Me | |||||
|
Charanko
Senior |
20-Jan-2021 17:14
|
||||
|
x 0
x 0 Alert Admin |
Tomorrow should be Sembcorp marine Vs Clearbridge | ||||
| Useful To Me Not Useful To Me | |||||
|
SMM770M
Member |
20-Jan-2021 17:09
|
||||
|
x 0
x 0 Alert Admin |
Hope ah. Keep hoping
|
||||
| Useful To Me Not Useful To Me | |||||